Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // April 27th, 2010 // 6:31 am
Rise and shine. Another day lies ahead. And no doubt, it will be a busy one. As always, there is much to do - meetings and deadlines beckon. While we attempt to hustle one of the short people off to the local schoolhouse, here are a few items to jumpstart your day. We hope it is a good one. And once again, do stay in touch…
AstraZeneca Wins Wider EU Crestor Labeling (Reuters)
Novo Nordisk Raises Forecasts (Bloomberg News)
Irish Reference Pricing Could Cause Shortages (PharmaTimes)
Abbott Court Loss Prompts Review Of Patent Standards (Daily Herald)
ACRO To Fund CRO Academic Research (OutsourcingPharma)
J&J Unit Denied Appeal Of Patent Decision (MarketWatch)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Abbott Laboratories, ACRO, ADHD, Association of Clinical Research Organizations, AstraZeneca, Concerta, Crestor, Ireland, Johnson & Johnson, Novo Nordisk, Patents, Reference Pricing, Victoza